Share

Medicare

ACS CAN advocates for policies that improve the Medicare program for individuals with cancer (including those who may be newly diagnosed, in active treatment and cancer survivors) as well as improving access to preventive services for individuals.

Medicare Resources:

ACS CAN filed a comment letter regarding the policies included in the Global Benchmark for Efficient Drug Pricing (GLOBE) Model proposed rule.

ACS CAN filed a comment letter regarding the policies included in the Guarding U.S. Against Rising Drug Costs (GUARD) Model proposed rule.

ACS CAN joined with 50 other organizations to applaud Representatives Jodey Arrington (R-TX) and Terri Sewell (D-AL) for sponsoring and prioritizing the passage of the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R. 842).

ACS CAN filed a comment letter regarding the following policies included in the calendar year 2026 Medicare Physician Fee Schedule proposed rule:

Earlier screening for cancer is important because when detected at later stages, treatments are more limited, and outcomes are generally poorer. Medicare enrollees should have access to multi-cancer screening tests when the benefit is clinically shown.

Earlier screening for cancer is important because when detected at later stages, treatments are more limited, and outcomes are generally poorer. Medicare enrollees should have access to multi-cancer screening tests when the benefit is clinically shown.

This ACS CAN chartbook provides cancer-specific data related to Medicare, including basic information about the program, a discussion of its components, characteristics of enrollees, coverage of services – specifically those related to prevention and screening – program expenditures and enrollees